107 related articles for article (PubMed ID: 5472052)
1. Prophylactic versus therapeutic oophorectomy in stage 1 and 2 breast cancer in Utah.
Matolo N; Smart CR
Rocky Mt Med J; 1970 Oct; 67(10):39-42. PubMed ID: 5472052
[No Abstract] [Full Text] [Related]
2. [Prophylactic radiological and surgical castration in cancer of the breast].
Marini G; Pistocchi F
Nunt Radiol; 1968 Jul; 34(7):659-66. PubMed ID: 5736513
[No Abstract] [Full Text] [Related]
3. TOTAL HYSTERECTOMY COMBINED WITH PROPHYLACTIC BILATERAL OOPHORECTOMY IN TREATMENT OF BREAST CANCER.
VARDEN LC; RICHTMEYER DC
Va Med Mon (1918); 1963 Oct; 90():501-4. PubMed ID: 14069382
[No Abstract] [Full Text] [Related]
4. Use of genetic testing and prophylactic mastectomy and oophorectomy in women with breast or ovarian cancer from families with a BRCA1 or BRCA2 mutation.
Meijers-Heijboer H; Brekelmans CT; Menke-Pluymers M; Seynaeve C; Baalbergen A; Burger C; Crepin E; van den Ouweland AW; van Geel B; Klijn JG
J Clin Oncol; 2003 May; 21(9):1675-81. PubMed ID: 12721241
[TBL] [Abstract][Full Text] [Related]
5. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group.
Metcalfe KA; Lubinski J; Ghadirian P; Lynch H; Kim-Sing C; Friedman E; Foulkes WD; Domchek S; Ainsworth P; Isaacs C; Tung N; Gronwald J; Cummings S; Wagner T; Manoukian S; Møller P; Weitzel J; Sun P; Narod SA;
J Clin Oncol; 2008 Mar; 26(7):1093-7. PubMed ID: 18195327
[TBL] [Abstract][Full Text] [Related]
6. The ABO blood groups and results of therapeutic oophorectomy for advanced carcinoma of the breast.
Lee YT
Surg Gynecol Obstet; 1971 May; 132(5):871-5. PubMed ID: 5555409
[No Abstract] [Full Text] [Related]
7. [The value of preventive castration in the treatment of breast cancer. Critical study of the record].
Juret P
J Chir (Paris); 1972 Jan; 103(1):49-62. PubMed ID: 5075477
[No Abstract] [Full Text] [Related]
8. Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution study.
Uyei A; Peterson SK; Erlichman J; Broglio K; Yekell S; Schmeler K; Lu K; Meric-Bernstam F; Amos C; Strong L; Arun B
Cancer; 2006 Dec; 107(12):2745-51. PubMed ID: 17109443
[TBL] [Abstract][Full Text] [Related]
9. [Castration in the treatment of mammary cancer. VII. Preventive and therapeutic castration].
García García G
Gac Med Mex; 1967 Sep; 97(9):1120-4. PubMed ID: 5611989
[No Abstract] [Full Text] [Related]
10. Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation.
Metcalfe KA; Foulkes WD; Kim-Sing C; Ainsworth P; Rosen B; Armel S; Poll A; Eisen A; Gilchrist D; Chudley A; Ghadirian P; Maugard C; Lemire EG; Sun P; Narod SA
Clin Genet; 2008 May; 73(5):474-9. PubMed ID: 18341607
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic oophorectomy in operable instances of carcinoma of the breast.
Bryant AJ; Weir JA
Surg Gynecol Obstet; 1981 Nov; 153(5):660-4. PubMed ID: 7292264
[TBL] [Abstract][Full Text] [Related]
12. Prophylactic oophorectomy for breast carcinoma.
Med J Aust; 1971 Apr; 1(17):884. PubMed ID: 5576801
[No Abstract] [Full Text] [Related]
13. [Clinical features and therapeutic management of male breast cancer (author's transl)].
Samonigg H; Fereberger W; Steindorfer P
Wien Klin Wochenschr; 1982 Apr; 94(7):172-6. PubMed ID: 7101952
[TBL] [Abstract][Full Text] [Related]
14. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
[TBL] [Abstract][Full Text] [Related]
15. Surgery for breast cancer.
George WD
Nurs Mirror Midwives J; 1975 Apr; 140(14):49-50. PubMed ID: 1038675
[No Abstract] [Full Text] [Related]
16. Comparison of prophylactic and therapeutic castration in breast carcinoma.
Fracchia AA; Murray DR; Farrow JH; Balachandra VK
Surg Gynecol Obstet; 1969 Aug; 129(2):270-6. PubMed ID: 5794401
[No Abstract] [Full Text] [Related]
17. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
[TBL] [Abstract][Full Text] [Related]
18. Laparoscopic oophorectomy in the management of breast disease.
Willsher P; Ali A; Jackson L
ANZ J Surg; 2008 Aug; 78(8):670-2. PubMed ID: 18796025
[TBL] [Abstract][Full Text] [Related]
19. [Castration following mastectomy?].
Berndt H
Dtsch Med Wochenschr; 1972 Aug; 97(32):1194-5. PubMed ID: 5044652
[No Abstract] [Full Text] [Related]
20. [The principles and limintations of surgical treatment of cancer of the breast].
Kholdin SA
Vopr Onkol; 1969; 15(7):10-6. PubMed ID: 5811134
[No Abstract] [Full Text] [Related]
[Next] [New Search]
